{"firm_pattern":"Pfizer","window_days":365,"note":"FDA dossier for one firm. Recalls + 510(k) clearances are matched on firm name; FAERS adverse events are matched best-effort on the patient_drugs_json field (some drug names contain firm names, some don't).","summary":{"recalls":0,"class_i_recalls":0,"clearances":0,"adverse_events":60,"adverse_event_deaths":1},"recalls":[],"clearances":[],"adverse_events":[{"safetyreportid":"26940228","receivedate":"2026-06-30","occurcountry":"US","patient_age":82,"patient_sex":2,"seriousness_death":0,"seriousness_hospitalization":1,"drugs":"[{\"name\":\"TYVASO\",\"brand\":\"TYVASO\",\"generic\":\"TREPROSTINIL\",\"substance\":\"TREPROSTINIL\",\"indication\":\"Pulmonary arterial hypertension\"},{\"name\":\"TYVASO\",\"brand\":\"TYVASO\",\"generic\":\"TREPROSTINIL\",\"subst","reactions":"[\"Peripheral swelling\",\"Pleural effusion\"]"},{"safetyreportid":"26194850","receivedate":"20251224","occurcountry":"US","patient_age":50,"patient_sex":2,"seriousness_death":null,"seriousness_hospitalization":null,"drugs":"[\"OPSUMIT\", \"ORENITRAM\", \"ORENITRAM\", \"ADEMPAS\", \"SYNTHROID\", \"DELSYM\", \"IMODIUM\", \"TYLENOL\", \"PEPCID\", \"FLUOXETINE HYDROCHLORIDE\", \"SODIUM CHLORIDE\", \"LAMOTRIGINE\", \"IMODIUM MULTI-SYMPTOM RELIEF\", \"P","reactions":"[\"Vomiting\", \"Nausea\", \"Abdominal discomfort\", \"Chest pain\", \"Headache\", \"Flushing\"]"},{"safetyreportid":"26175848","receivedate":"20251218","occurcountry":"CA","patient_age":64,"patient_sex":null,"seriousness_death":2,"seriousness_hospitalization":2,"drugs":"[\"ONPATTRO\", \"ONPATTRO\", \"PFIZER-BIONTECH COVID-19 VACCINE\", \"CIMETIDINE\", \"TYLENOL\", \"DEXAMETHASONE\", \"DIPHENHYDRAMINE\", \"ACETAMINOPHEN\", \"VITAMIN B COMPLEX\", \"VITAMIN B12\", \"FISH OIL\", \"VITAMINS\", \"","reactions":"[\"Urinary tract infection\", \"Head discomfort\", \"Hypotension\", \"Asthenia\", \"Fatigue\", \"Condition aggravated\", \"Discomfort\", \"Dizziness\", \"Dyspnoea\", \"Heart rate decreased\", \"Incoherent\", \"Malaise\", \"So"},{"safetyreportid":"26166119","receivedate":"20251216","occurcountry":"US","patient_age":70,"patient_sex":2,"seriousness_death":2,"seriousness_hospitalization":1,"drugs":"[\"TYVASO\", \"TYVASO\", \"TYVASO\", \"TYVASO\", \"PLAQUENIL\", \"ESCITALOPRAM OXALATE\", \"NIFEDIPINE\", \"SYNTHROID\", \"LOSARTAN POTASSIUM\", \"JARDIANCE\", \"TRACLEER\", \"PFIZER-BIONTECH COVID-19 VACCINE\", \"NEXIUM\", \"A","reactions":"[\"Pneumonia\", \"Nervousness\", \"Fatigue\", \"Therapy interrupted\", \"Device breakage\"]"},{"safetyreportid":"26156316","receivedate":"20251215","occurcountry":"US","patient_age":15,"patient_sex":2,"seriousness_death":2,"seriousness_hospitalization":2,"drugs":"[\"MYCOPHENOLATE MOFETIL\", \"PREDNISOLONE\", \"PREDNISOLONE\", \"PREDNISOLONE\", \"PREDNISOLONE\", \"Immunoglobulin\", \"Immunoglobulin\", \"SOLU-MEDROL\", \"RITUXIMAB\", \"RITUXIMAB\", \"PFIZER-BIONTECH COVID-19 VACCINE","reactions":"[\"Gastrointestinal disorder\", \"Off label use\"]"},{"safetyreportid":"26152363","receivedate":"20251214","occurcountry":"US","patient_age":62,"patient_sex":2,"seriousness_death":null,"seriousness_hospitalization":null,"drugs":"[\"TYVASO\", \"YUTREPIA\", \"YUTREPIA\", \"ATORVASTATIN CALCIUM\", \"LEVOCETIRIZINE DIHYDROCHLORIDE\", \"IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE\", \"ROFLUMILAST\", \"FUROSEMIDE\", \"VITAMIN C\", \"VITAMIN D2\", \"PREDN","reactions":"[\"Cough\", \"Epistaxis\", \"Diarrhoea\"]"},{"safetyreportid":"26137508","receivedate":"20251209","occurcountry":"US","patient_age":null,"patient_sex":2,"seriousness_death":2,"seriousness_hospitalization":2,"drugs":"[\"WINREVAIR\", \"WINREVAIR\", \"WINREVAIR\", \"WINREVAIR\", \"Milk of magnesia (Magnesium hydroxide)\", \"ALPRAZOLAM\", \"VITAMIN C\", \"LEVOTHYROXINE SODIUM\", \"POTASSIUM CHLORIDE\", \"OPSUMIT\", \"TRELEGY ELLIPTA\", \"P","reactions":"[\"Memory impairment\"]"},{"safetyreportid":"26133063","receivedate":"20251209","occurcountry":"US","patient_age":23,"patient_sex":2,"seriousness_death":2,"seriousness_hospitalization":2,"drugs":"[\"REMODULIN\", \"REMODULIN\", \"TADALAFIL\", \"PFIZER-BIONTECH COVID-19 VACCINE\", \"WINREVAIR\", \"AMBRISENTAN\"]","reactions":"[\"Complication associated with device\", \"Device issue\", \"Device issue\"]"},{"safetyreportid":"26136580","receivedate":"20251209","occurcountry":"US","patient_age":12,"patient_sex":2,"seriousness_death":2,"seriousness_hospitalization":1,"drugs":"[\"PREDNISONE\", \"PREDNISONE\", \"PFIZER-BIONTECH COVID-19 VACCINE\", \"TYLENOL\", \"METHYLPREDNISOLONE\"]","reactions":"[\"Blood creatinine increased\", \"Drug effective for unapproved indication\", \"Off label use\"]"},{"safetyreportid":"26120646","receivedate":"20251204","occurcountry":"US","patient_age":66,"patient_sex":2,"seriousness_death":null,"seriousness_hospitalization":null,"drugs":"[\"REMODULIN\", \"REMODULIN\", \"LEVOFLOXACIN\", \"OXYBUTYNIN CHLORIDE\", \"VITAMIN C\", \"FUROSEMIDE\", \"PERCOCET\", \"AMMONIUM LACTATE\", \"PFIZER-BIONTECH COVID-19 VACCINE\", \"LEVOTHYROXINE SODIUM\", \"COLESTIPOL HYD","reactions":"[\"Lymphoedema\", \"Headache\", \"Malaise\", \"Tremor\", \"Retching\", \"Limb injury\", \"Pyrexia\", \"Urinary tract infection\", \"Fungal infection\", \"Lung opacity\"]"},{"safetyreportid":"26119961","receivedate":"20251204","occurcountry":"US","patient_age":83,"patient_sex":1,"seriousness_death":2,"seriousness_hospitalization":1,"drugs":"[\"REMODULIN\", \"REMODULIN\", \"KEYTRUDA\", \"CVS coenzyme q 10\", \"TYLENOL EXTRA STRENGTH\", \"PROMETHAZINE\", \"PFIZER-BIONTECH COVID-19 VACCINE\", \"ROPINIROLE HYDROCHLORIDE\", \"TADALAFIL\", \"DOXYCYCLINE HYCLATE\"","reactions":"[\"Fall\", \"Craniofacial fracture\", \"Device dislocation\"]"},{"safetyreportid":"26109054","receivedate":"20251201","occurcountry":"US","patient_age":null,"patient_sex":null,"seriousness_death":2,"seriousness_hospitalization":1,"drugs":"[\"YUTREPIA\", \"YUTREPIA\", \"YUTREPIA\", \"YUTREPIA\", \"YUTREPIA\", \"YUTREPIA\", \"YUTREPIA\", \"YUTREPIA\", \"YUTREPIA\", \"ELIQUIS\", \"SILDENAFIL CITRATE\", \"FISH OIL\", \"FUROSEMIDE\", \"MINERALS\\\\VITAMINS\", \"POTASSIUM","reactions":"[\"Oxygen saturation decreased\", \"Lung disorder\", \"Arthralgia\", \"Mobility decreased\", \"Asthenia\", \"Feeling of body temperature change\", \"Heart rate increased\", \"Heart rate decreased\", \"Confusional stat"},{"safetyreportid":"26100994","receivedate":"20251128","occurcountry":"US","patient_age":61,"patient_sex":2,"seriousness_death":2,"seriousness_hospitalization":2,"drugs":"[\"RINVOQ\", \"RINVOQ\", \"PROLIA\", \"PFIZER-BIONTECH COVID-19 VACCINE\", \"CYCLOBENZAPRINE\", \"OMEPRAZOLE\", \"NAPROXEN\", \"HYZAAR\"]","reactions":"[\"Squamous cell carcinoma\"]"},{"safetyreportid":"26095149","receivedate":"20251127","occurcountry":"US","patient_age":null,"patient_sex":2,"seriousness_death":2,"seriousness_hospitalization":2,"drugs":"[\".ALPHA.1-PROTEINASE INHIBITOR HUMAN\", \".ALPHA.1-PROTEINASE INHIBITOR HUMAN\", \"EPINEPHRINE\", \"FUROSEMIDE\", \"LEVOTHYROXINE SODIUM\", \"SODIUM CHLORIDE\", \"ALBUTEROL SULFATE\", \"ALBUTEROL SULFATE\", \"ALEVE\"","reactions":"[\"Pneumonia\", \"Respiratory tract infection\", \"Multiple allergies\", \"Wheezing\", \"Product use issue\", \"Insurance issue\", \"Tooth infection\", \"Breath sounds abnormal\", \"Dyspnoea exertional\", \"Sinusitis\", "},{"safetyreportid":"26090759","receivedate":"20251126","occurcountry":"US","patient_age":39,"patient_sex":2,"seriousness_death":2,"seriousness_hospitalization":1,"drugs":"[\"ORENITRAM\", \"ORENITRAM\", \"ORENITRAM\", \"ORENITRAM\", \"ORENITRAM\", \"SILDENAFIL\", \"CARVEDILOL\", \"SPIRONOLACTONE\", \"HYDROXYZINE HYDROCHLORIDE\", \"AZATHIOPRINE\", \"POTASSIUM CHLORIDE\", \"ACETAMINOPHEN\\\\HYDRO","reactions":"[\"Abdominal pain\", \"Abdominal distension\"]"},{"safetyreportid":"26078203","receivedate":"20251122","occurcountry":"US","patient_age":50,"patient_sex":2,"seriousness_death":2,"seriousness_hospitalization":1,"drugs":"[\"ORENITRAM\", \"ORENITRAM\", \"ORENITRAM\", \"SAPHNELO\", \"FLUTICASONE PROPIONATE\", \"FOLIC ACID\", \"OPSUMIT\", \"PFIZER-BIONTECH COVID-19 VACCINE\", \"PREDNISONE\", \"SILDENAFIL CITRATE\", \"HYDROXYCHLOROQUINE SULFA","reactions":"[\"Oxygen saturation decreased\"]"},{"safetyreportid":"26078241","receivedate":"20251122","occurcountry":"US","patient_age":null,"patient_sex":1,"seriousness_death":2,"seriousness_hospitalization":2,"drugs":"[\"TYVASO\", \"TYVASO\", \"FLUTICASONE PROPIONATE\", \"Artificial tears\", \"COLCHICINE\", \"MIRALAX\", \"VITAMIN D3\", \"ACETAMINOPHEN\\\\HYDROCODONE\", \"METOLAZONE\", \"TAMSULOSIN HYDROCHLORIDE\", \"SILDENAFIL CITRATE\", ","reactions":"[\"Sleep apnoea syndrome\", \"Device temperature issue\", \"Device issue\"]"},{"safetyreportid":"26062163","receivedate":"20251119","occurcountry":"US","patient_age":null,"patient_sex":1,"seriousness_death":2,"seriousness_hospitalization":2,"drugs":"[\"TYVASO DPI\", \"TYVASO DPI\", \"TYVASO DPI\", \"Vicks dayquil/nyquil\", \"FUROSEMIDE\", \"LIPITOR\", \"PREDNISONE\", \"OFEV\", \"VITAMIN D3\", \"TRELEGY ELLIPTA\", \"COENZYME Q10\", \"PFIZER-BIONTECH COVID-19 VACCINE\", \"","reactions":"[\"Fatigue\", \"Dyspnoea\"]"},{"safetyreportid":"26052737","receivedate":"20251117","occurcountry":"EU","patient_age":41,"patient_sex":1,"seriousness_death":2,"seriousness_hospitalization":1,"drugs":"[\"ADRIACIN\", \"ANAKINRA\", \"AXICABTAGENE CILOLEUCEL\", \"CYCLOPHOSPHAMIDE\", \"CYCLOPHOSPHAMIDE\", \"CYTARABINE\", \"CYTARABINE\", \"DECADRON (DEXAMETHASONE SODIUM PHOSPHATE)\", \"DECADRON (DEXAMETHASONE SODIUM PHO","reactions":"[\"COVID-19\", \"Tuberculosis\", \"Respiratory distress\", \"Immune effector cell-associated neurotoxicity syndrome\", \"Epilepsy\", \"Encephalitis\", \"Aphasia\", \"Cytokine release syndrome\", \"Aspergillus infectio"},{"safetyreportid":"26048481","receivedate":"20251114","occurcountry":"JP","patient_age":55,"patient_sex":1,"seriousness_death":2,"seriousness_hospitalization":1,"drugs":"[\"FENOFIBRATE\", \"MOLNUPIRAVIR\", \"MOLNUPIRAVIR\", \"MOLNUPIRAVIR\", \"LURASIDONE\", \"LITHIUM CARBONATE\", \"TRAZODONE\", \"SUVOREXANT\", \"PEMAFIBRATE\", \"PEMAFIBRATE\", \"MODERNA COVID-19 VACCINE\", \"MODERNA COVID-1","reactions":"[\"Somatic hallucination\", \"Hallucination\", \"SARS-CoV-2 test positive\", \"SARS-CoV-2 test positive\", \"SARS-CoV-2 test positive\", \"Drug interaction\", \"Therapeutic response decreased\"]"},{"safetyreportid":"26039986","receivedate":"20251113","occurcountry":"US","patient_age":null,"patient_sex":1,"seriousness_death":2,"seriousness_hospitalization":2,"drugs":"[\"WINREVAIR\", \"WINREVAIR\", \"WINREVAIR\", \"WINREVAIR\", \"JARDIANCE\", \"PFIZER-BIONTECH COVID-19 VACCINE\", \"MAGNESIUM OXIDE\", \"ELIQUIS\", \"CIALIS\", \"PLAVIX\", \"TORSEMIDE\", \"ONDANSETRON HYDROCHLORIDE\", \"ORENI","reactions":"[\"Injection site nodule\", \"Injection site bruising\"]"},{"safetyreportid":"26036808","receivedate":"20251112","occurcountry":"EU","patient_age":41,"patient_sex":1,"seriousness_death":2,"seriousness_hospitalization":1,"drugs":"[\"YESCARTA\", \"ANAKINRA\", \"CYCLOPHOSPHAMIDE\", \"CYCLOPHOSPHAMIDE\", \"CYTARABINE\", \"DEXAMETHASONE\", \"DOXORUBICIN HYDROCHLORIDE\", \"ETHAMBUTOL\", \"ETHAMBUTOL\", \"ETOPOSIDE PHOSPHATE\", \"FLUDARABINE\", \"ISONIAZI","reactions":"[\"Bronchopulmonary aspergillosis\", \"Cytokine release syndrome\", \"Immune effector cell-associated neurotoxicity syndrome\", \"Febrile neutropenia\"]"},{"safetyreportid":"26024013","receivedate":"20251111","occurcountry":"US","patient_age":67,"patient_sex":2,"seriousness_death":2,"seriousness_hospitalization":2,"drugs":"[\"RINVOQ\", \"RINVOQ\", \"RINVOQ\", \"PLAQUENIL\", \"GABAPENTIN\", \"LEVOTHYROXINE\", \"LIPITOR\", \"NEXIUM\", \"LAMICTAL\", \"LEXAPRO\", \"GABAPENTIN\", \"NORVASC\", \"PRINIVIL\", \"LEVOTHYROXINE\", \"FERRIC POLYSACCHARIDE COMP","reactions":"[\"Basal cell carcinoma\"]"},{"safetyreportid":"26021115","receivedate":"20251110","occurcountry":"US","patient_age":null,"patient_sex":2,"seriousness_death":null,"seriousness_hospitalization":null,"drugs":"[\"TYVASO DPI\", \"TYVASO DPI\", \"TYVASO DPI\", \"TYVASO DPI\", \"TYVASO DPI\", \"TYVASO DPI\", \"TYVASO DPI\", \"TYVASO DPI\", \"TYVASO DPI\", \"VALTREX\", \"UPTRAVI\", \"FOLIC ACID\", \"LYRICA\", \"DUPIXENT\", \"NYSTATIN\", \"OP","reactions":"[\"Pain in extremity\", \"Headache\", \"Muscular weakness\", \"Dysphonia\", \"Diarrhoea\", \"Cough\", \"Productive cough\", \"Taste disorder\", \"Candida infection\", \"Oral candidiasis\", \"Dry mouth\", \"Decreased appetit"},{"safetyreportid":"26014481","receivedate":"20251108","occurcountry":"US","patient_age":null,"patient_sex":2,"seriousness_death":2,"seriousness_hospitalization":2,"drugs":"[\"REMODULIN\", \"REMODULIN\", \"MORPHINE SULFATE\", \"ZOLOFT\", \"SODIUM CHLORIDE\", \"OPSUMIT\", \"MIRTAZAPINE\", \"PFIZER-BIONTECH COVID-19 VACCINE\", \"GABAPENTIN\", \"POTASSIUM\", \"ACETAMINOPHEN\\\\HYDROCODONE\", \"SOTA","reactions":"[\"Feeling abnormal\", \"Headache\", \"Musculoskeletal pain\", \"Pain\", \"Condition aggravated\", \"Device wireless communication issue\", \"Product administration interrupted\"]"}],"drug_labels":[{"set_id":"2b34d62d-e02a-4af3-bc0d-1571dd4ee76d","brand_name":"Lorbrena","generic_name":"LORLATINIB","product_type":"HUMAN PRESCRIPTION DRUG","route":"ORAL","effective_time":"20260626","substance_name":"LORLATINIB","indications_snippet":"1 INDICATIONS AND USAGE LORBRENA ® is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as det"},{"set_id":"6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6","brand_name":"Caduet","generic_name":"AMLODIPINE AND ATORVASTATIN","product_type":"HUMAN PRESCRIPTION DRUG","route":"ORAL","effective_time":"20260625","substance_name":"AMLODIPINE BESYLATE","indications_snippet":"1 INDICATIONS AND USAGE CADUET (amlodipine and atorvastatin) is indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate. CADUET is a combination of amlodipine bes"},{"set_id":"a2cc631e-13a6-40c2-acf9-065ccedfb90a","brand_name":"HYMPAVZI","generic_name":"MARSTACIMAB-HNCQ","product_type":"HUMAN PRESCRIPTION DRUG","route":"SUBCUTANEOUS","effective_time":"20260622","substance_name":"MARSTACIMAB","indications_snippet":"1 INDICATIONS AND USAGE HYMPAVZI is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 6 years of age and older with: • hemophil"},{"set_id":"258e1602-a3cf-4ccc-ca80-73dbbfb812ff","brand_name":"Premarin","generic_name":"ESTROGENS, CONJUGATED","product_type":"HUMAN PRESCRIPTION DRUG","route":"ORAL","effective_time":"20260604","substance_name":"ESTROGENS, CONJUGATED","indications_snippet":"1 INDICATIONS AND USAGE PREMARIN is a mixture of estrogens indicated for: • Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause ( 1.1 ) • Treatment of Moderate to Severe Vulvar and Vag"},{"set_id":"b9ef541a-93c8-4428-ba45-398aa0b327d1","brand_name":"Azulfidine EN-tabs","generic_name":"SULFASALAZINE","product_type":"HUMAN PRESCRIPTION DRUG","route":"ORAL","effective_time":"20260529","substance_name":"SULFASALAZINE","indications_snippet":"INDICATIONS AND USAGE AZULFIDINE EN-tabs Tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; b) for the prolongat"},{"set_id":"ddbe69f3-bd55-45f3-a64f-f60226c744c4","brand_name":"Azulfidine","generic_name":"SULFASALAZINE","product_type":"HUMAN PRESCRIPTION DRUG","route":"ORAL","effective_time":"20260529","substance_name":"SULFASALAZINE","indications_snippet":"INDICATIONS AND USAGE AZULFIDINE Tablets are indicated: • in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and • for the prolongation of"},{"set_id":"a2883ca1-5a9a-4259-9d80-46ab67274384","brand_name":"Flagyl","generic_name":"METRONIDAZOLE","product_type":"HUMAN PRESCRIPTION DRUG","route":"ORAL","effective_time":"20260522","substance_name":"METRONIDAZOLE","indications_snippet":"INDICATIONS AND USAGE Symptomatic Trichomoniasis . FLAGYL 375 capsules are indicated for the treatment of T. vaginalis infection in females and males when the presence of the trichomonad has been conf"},{"set_id":"08098cb2-c048-4640-f387-6beec4a38936","brand_name":"Protonix Delayed-Release","generic_name":"PANTOPRAZOLE SODIUM","product_type":"HUMAN PRESCRIPTION DRUG","route":"ORAL","effective_time":"20260518","substance_name":"PANTOPRAZOLE SODIUM","indications_snippet":"1 INDICATIONS AND USAGE PROTONIX For Delayed-Release Oral Suspension and PROTONIX Delayed-Release Tablets are indicated for: PROTONIX is a proton pump inhibitor (PPI) indicated for the following: • Sh"},{"set_id":"1b4121ee-a733-4456-a917-be2603477839","brand_name":"Vyndaqel","generic_name":"TAFAMIDIS MEGLUMINE","product_type":"HUMAN PRESCRIPTION DRUG","route":"ORAL","effective_time":"20260512","substance_name":"TAFAMIDIS MEGLUMINE","indications_snippet":"1. INDICATIONS AND USAGE VYNDAQEL and VYNDAMAX are indicated for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiov"},{"set_id":"b9c5e894-27d2-4245-a653-df986fed3c56","brand_name":"Trazimera","generic_name":"TRASTUZUMAB-QYYP","product_type":"HUMAN PRESCRIPTION DRUG","route":"INTRAVENOUS","effective_time":"20260410","substance_name":"TRASTUZUMAB","indications_snippet":"1 INDICATIONS AND USAGE TRAZIMERA is a HER2/neu receptor antagonist indicated in adults for: • The treatment of HER2-overexpressing breast cancer. ( 1.1 , 1.2 ) • The treatment of HER2-overexpressing "},{"set_id":"f0ff4f27-5185-4881-a749-c6b7a0ca5696","brand_name":"CHANTIX","generic_name":"VARENICLINE TARTRATE","product_type":"HUMAN PRESCRIPTION DRUG","route":"ORAL","effective_time":"20260123","substance_name":"VARENICLINE TARTRATE","indications_snippet":"1 INDICATIONS AND USAGE CHANTIX is indicated for use as an aid to smoking-cessation treatment. CHANTIX is a nicotinic receptor partial agonist indicated for use as an aid to smoking-cessation treatmen"},{"set_id":"fa3cbd5d-677c-4b19-9032-d9182cb69a83","brand_name":"ELELYSO","generic_name":"TALIGLUCERASE ALFA","product_type":"HUMAN PRESCRIPTION DRUG","route":"INTRAVENOUS","effective_time":"20251229","substance_name":"TALIGLUCERASE ALFA","indications_snippet":"1 INDICATIONS AND USAGE ELELYSO is indicated for the treatment of patients 4 years of age and older with a confirmed diagnosis of Type 1 Gaucher disease. ELELYSO is a hydrolytic lysosomal glucocerebro"},{"set_id":"4ab27d2f-e385-4e9c-b324-fa69c10b855a","brand_name":"Vizimpro","generic_name":"DACOMITINIB","product_type":"HUMAN PRESCRIPTION DRUG","route":"ORAL","effective_time":"20251218","substance_name":"DACOMITINIB","indications_snippet":"1 INDICATIONS AND USAGE VIZIMPRO is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion "},{"set_id":"fd826e47-1b77-4ffd-bb22-fda3379903b0","brand_name":"Tygacil","generic_name":"TIGECYCLINE","product_type":"HUMAN PRESCRIPTION DRUG","route":"INTRAVENOUS","effective_time":"20251118","substance_name":"TIGECYCLINE","indications_snippet":"1 INDICATIONS AND USAGE TYGACIL is a tetracycline class antibacterial indicated in patients 18 years of age and older for: • Complicated skin and skin structure infections ( 1.1 ) • Complicated intra-"},{"set_id":"600fe842-45d9-4d68-9ef2-456dbbebaa11","brand_name":"ARTHROTEC","generic_name":"DICLOFENAC SODIUM AND MISOPROSTOL","product_type":"HUMAN PRESCRIPTION DRUG","route":"ORAL","effective_time":"20250814","substance_name":"DICLOFENAC SODIUM","indications_snippet":"1 INDICATIONS AND USAGE ARTHROTEC is indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in adult patients at high risk of developing NSAID-induced gastric and "},{"set_id":"d23ab39c-b6ec-41cf-a529-9dd2852c9d9a","brand_name":"Nivestym","generic_name":"FILGRASTIM-AAFI","product_type":"HUMAN PRESCRIPTION DRUG","route":"SUBCUTANEOUS","effective_time":"20250812","substance_name":"FILGRASTIM","indications_snippet":"1 INDICATIONS AND USAGE NIVESTYM is a leukocyte growth factor indicated to • Decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receivi"},{"set_id":"3af26b0d-8ad0-44e1-a538-8bdb5ab39374","brand_name":"RETACRIT","generic_name":"EPOETIN ALFA-EPBX","product_type":"HUMAN PRESCRIPTION DRUG","route":"INTRAVENOUS","effective_time":"20250622","substance_name":"EPOETIN","indications_snippet":"1 INDICATIONS AND USAGE RETACRIT is an erythropoiesis-stimulating agent (ESA) indicated for: • Treatment of anemia due to o Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis ( 1"},{"set_id":"87e2da8d-432c-4ed5-67a1-dc26294b2295","brand_name":"Premarin","generic_name":"CONJUGATED ESTROGENS","product_type":"HUMAN PRESCRIPTION DRUG","route":"INTRAMUSCULAR","effective_time":"20250530","substance_name":"ESTROGENS, CONJUGATED","indications_snippet":"INDICATIONS AND USAGE Premarin Intravenous (conjugated estrogens, USP) for injection is indicated in the treatment of abnormal uterine bleeding due to hormonal imbalance in the absence of organic path"},{"set_id":"8ab9d90d-2f7f-4599-a44f-3d0a8f8ab623","brand_name":"Zosyn in Galaxy Containers","generic_name":"TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM","product_type":"HUMAN PRESCRIPTION DRUG","route":"INTRAVENOUS","effective_time":"20230315","substance_name":"PIPERACILLIN SODIUM","indications_snippet":"1 INDICATIONS AND USAGE ZOSYN is a combination of piperacillin, a penicillin-class antibacterial and tazobactam, a beta-lactamase inhibitor, indicated for the treatment of: • Intra-abdominal infection"}]}